Business
Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets
ZUG, Switzerland, April 15, 2025--Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China.1-7,11-14 This follows Sculptra’s approval by China’s National Medical Products Administration for correcting mid-facial volume loss and/or contour deficiencies last year. Sculptra – which works with the body’s natural processes to achieve healthier, radiant skin and a more youthful appearance – will now
About this update from Galderma Group Ag
[{"type":"image","alt":"Dr. Luiz Avelar – What is the value of introducing Sculptra to the injectable aesthetics market in China?","displaySize":"","headline":null,"caption":"Dr. Luiz Avelar – What is the value of introducing Sculptra to the injectable aesthetics market in China?","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1920,"height":1080,"url":"https://media.zenfs.com/en/business-wire.com/ea2d1b5fbe38c28d06f3ef4fcb991345"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MTcAUymPmUWc5BX22BiueQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/ea2d1b5fbe38c28d06f3ef4fcb991345","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/TooNaTBYoF4bSWsbxAO8qQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/ea2d1b5fbe38c28d06f3ef4fcb991345","width":1200,"height":675}},"lazy":false},{"type":"image","alt":"Sculptra Media Factsheet","displaySize":"","headline":null,"caption":"Sculptra Media Factsheet","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":339,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/744a28a52b7ac22375b89120c83d34be"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oV2cgUnRzxjzGljQZl6ryA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTkwNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/744a28a52b7ac22375b89120c83d34be","width":339,"height":480}}},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/44930dd1e78102a1b83fbd0991a480de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dbuerzANR94Tlaqvl1VWLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/44930dd1e78102a1b83fbd0991a480de","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/IxI2Ht9d9SSDForWCrSxBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/44930dd1e78102a1b83fbd0991a480de","width":823,"height":209}}},{"type":"list","items":[{"val":[{"type":"text","content":"Sculptra®, the first proven regenerative biostimulator, will provide new options for patients in China w...